通过USP9X/NDRG3在KRAS驱动的癌症发育中对KRAS的抗蛋白质调节
Han Koo1,2, Kyung Chan Park1,2, Hyun Ahm Sohn1
1Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Nature communications
|January 17, 2025
概括
KRAS突变癌症的生长依赖于NDRG3蛋白质. 通过USP9X对KRAS-NDRG3相互作用进行二基化来抑制KRAS-NDRG3,为KRAS驱动的癌症提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 激活KRAS突变在癌症中很常见,但很难治疗.
- 向KRAS仍然是瘤学中的一个重大挑战.
研究的目的:
- 为了研究KRAS蛋白的翻译后调节.
- 确定针对KRAS驱动的癌症的新型治疗策略.
主要方法:
- 研究了KRAS,NDRG3和USP9X之间的相互作用.
- 使用了有条件的KrasG12D敲进小鼠模型的胰腺管道腺癌.
- 使用主导负NDRG3片段来破坏KRAS-NDRG3相互作用.
主要成果:
- NDRG3对KRAS和USP9X进行了支架,促进了KRAS的剥离和升级.
- 克拉斯蛋白的表达,信号和生长依赖于克拉斯突变细胞中的NDRG3.
- 在体内,NDRG3枯竭抑制了Kras蛋白表达和胰腺内皮质瘤.
- 破坏KRAS-NDRG3相互作用抑制了KRAS蛋白表达和癌细胞生长.
结论:
- 通过USP9X/NDRG3对KRAS蛋白的二基化对于KRAS驱动的癌症发展至关重要.
- 针对KRAS-NDRG3相互作用,为KRAS成的癌症提供了一个有前途的治疗方法.
相关概念视频
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


